WELLESLEY, Mass., Jan. 3 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. , today announced that Robert L. Bratzler, Ph.D., Coley’s President and Chief Executive Officer, plans to provide a corporate presentation at the 25th Annual JPMorgan Healthcare Conference on January 9, 2007 at 11 a.m. Pacific time at the Westin St. Francis in San Francisco, CA.
Interested parties may access an audio webcast of the presentation by visiting the Coley Pharmaceutical Group website at http://www.coleypharma.com. A replay of the webcast will be archived on the “Investor Events” page in the Investor Center section of the Coley website for two weeks until January 23, 2007.
About Coley Pharmaceutical Group
Coley Pharmaceutical Group, Inc. is an international biopharmaceutical company, headquartered in Wellesley, Massachusetts, USA, that discovers and develops TLR Therapeutics(TM), a new class of investigational drug candidates that direct the human immune system to fight cancers, infectious disease, and asthma and allergy. Coley has established a pipeline of four TLR Therapeutic product candidates currently advancing through clinical development either independently or with partners, and additional product candidates in preclinical development. Coley has product development, research and license agreements with Pfizer, sanofi-aventis, Novartis Vaccines & Diagnostics (formerly Chiron), GlaxoSmithKline and the United States government. For further information on Coley Pharmaceutical Group please visit www.coleypharma.com.
Coley Pharmaceutical Group, Inc.
CONTACT: Susan Hager, Senior Director, Investor Relations and CorporateCommunications of Coley Pharmaceutical Group, Inc., +1-781-431-9079, orshager@coleypharma.com, or Karen L. Bergman, +1-650-575-1509, orkbergman@bccpartners.com, or Michelle Corral, +1-415-794-8662, ormcorral@bccpartners.com, both of BCC Partners for Coley PharmaceuticalGroup, Inc.
Web site: http://www.coleypharma.com/
